CTE 0.00% 88.0¢ cryosite limited

Clinical Trial News, page-5

  1. 1,187 Posts.
    lightbulb Created with Sketch. 591
    Initiatives to facilitate clinical trials in Australia should be welcomed by Cryosite.

    Clearly, the more trials - and the more participants - the bigger the boost for CTE business.

    Now, a collaborative group of stakeholders trading under the monika
    CT:IQ/Clinical Trials: Impact & Quality has launched the GREET Project - a Guideline to Recruitment: Examining Experiences at Clinical Trial sites.

    The project aims to better understand the barriers to clinical trial recruitment at the site level with the objective of producing recommendations for optimising recruitment.

    The survey is aimed at clinical research sites and sponsors/CROs in Australia.

    The study have been approved by the Macquarie University Human Research Ethics Committee (Project ID 5764).

    Principal Investigator is Radhika Butala from Macquarie University. Project Manager is Sonia Harvey.

    The summary of GREET survey findings/recommendations will be published on the CT:IQ website at the end of 2019.
 
watchlist Created with Sketch. Add CTE (ASX) to my watchlist
(20min delay)
Last
88.0¢
Change
0.000(0.00%)
Mkt cap ! $42.95M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1000 90.0¢
 

Sellers (Offers)

Price($) Vol. No.
$1.10 100000 1
View Market Depth
Last trade - 16.12pm 11/10/2024 (20 minute delay) ?
CTE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.